Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularization

Masanobu Ishii; Osamu Iida; Shinjo Sonoda; Nobuhiro Suematsu; Akiko Matsuo; Tairo Kurita; Kenshi Yamanaga; Tatsuya Saigusa; Kenji Yaginuma; Satoru Suwa; Jun Kikuchi; Yuetsu Kikuta; Yasunori Yamamoto; Kenichi Tsujita; Fumitoshi Toyota; Ryosuke Itakura; Hidenobu Terai; Shoichi Kuramitsu; Nobuhiro Tanaka; Ken Yokoyama; Tomohiro Sakamoto; Taku Asano; Noriyoshi Kanemura; Yohei Sasaki; Hiroyuki Isogai; Ken Harada; Takayuki Ishihara; Manabu Ogita; Mika Hirabayashi; Yasutsugu Shiono; Kazunori Horie; Hitoshi Matsuo; Hiroyoshi Yokoi; Takashi Yamada; Hirofumi Ohashi; Katsuhiko Masamura; Hiroaki Takashima

doi:10.1093/ehjcvp/pvac008

Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularization

Masanobu Ishii(Kumamoto Health Science University), Osamu Iida(Kansai Rosai Hospital), Shinjo Sonoda(University of Occupational and Environmental Health Japan), Nobuhiro Suematsu(Saiseikai Fukuoka General Hospital), Akiko Matsuo(Japanese Red Cross Society Kyoto Daini Hospital), Tairo Kurita(Mie University), Kenshi Yamanaga(Kumamoto University), Tatsuya Saigusa(Shinshu University), Kenji Yaginuma(Juntendo University Urayasu Hospital), Satoru Suwa(Juntendo University Shizuoka Hospital), Jun Kikuchi(Keio University), Yuetsu Kikuta(Imperial College London), Yasunori Yamamoto(Fukuyama Cardiovascular Hospital), Kenichi Tsujita(Kumamoto University), Fumitoshi Toyota(Fukuoka Hospital), Ryosuke Itakura(Japanese Red Cross Society Kyoto Daini Hospital), Hidenobu Terai(Kanazawa Hospital), Shoichi Kuramitsu(Kokura Memorial Hospital), Nobuhiro Tanaka(Tokyo Medical University Hachioji Medical Center), Ken Yokoyama(Juntendo University Urayasu Hospital), Tomohiro Sakamoto(Saiseikai Kumamoto Hospital), Taku Asano(Amsterdam UMC Location University of Amsterdam), Noriyoshi Kanemura(Kinan Hospital), Yohei Sasaki(Chubu Rosai Hospital), Hiroyuki Isogai(Aichi Medical University), Ken Harada(Ibaraki University), Takayuki Ishihara(Kansai Rosai Hospital), Manabu Ogita(Juntendo University Shizuoka Hospital), Mika Hirabayashi(Gifu Heart Center), Yasutsugu Shiono(Imperial College London), Kazunori Horie(Sendai Kousei Hospital), Hitoshi Matsuo, Hiroyoshi Yokoi(Kurume University), Takashi Yamada(Osaka University of Pharmaceutical Sciences), Hirofumi Ohashi(National Institute of Infectious Diseases), Katsuhiko Masamura(Nakamura Memorial Hospital), Hiroaki Takashima(Aichi Medical University)

European Heart Journal - Cardiovascular Pharmacotherapy

January 29, 2022

10.1093/ehjcvp/pvac008

Cited by 12

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

|JAMA|2019|848

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

|The Lancet|2018|793

JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome

|Circulation Journal|2019|582

Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention

|Journal of the American College of Cardiology|2015|453

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

|New England Journal of Medicine|2024|410